Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01502306 · ClinicalTrials.gov registry record · Phase 3
A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline
A Phase 3 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,816
- Enrollment target
NCT01502306: Completed Phase 3 study, sponsored by University of California, San Diego.
NCT01502306 is a Phase 3 study that has completed, run by University of California, San Diego. The registered enrollment target is 3,816 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (394% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01502306, a Phase 3 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,816 participants
- Enrollment target
Study Summary
California Smokers' Helpline will conduct a randomized trial to evaluate 3 strategies of services and/or incentives on smoking cessation rates. This project has the following specific aims: 1. To increase tobacco cessation among Medi-Cal beneficiaries who currently smoke, and to improve the management of diabetes and other chronic disease by means of tobacco cessation. 2. Demonstrate that tobacco cessation benefits that are well promoted and barrier free and include modest incentives, are effective in reducing smoking prevalence, lowering Medi-Cal health care costs, and improving health outcomes for diabetes management in particular.
Primary Outcome
At a given point in time (in this case, 7 months after program registration), quitline participants are asked whether they have used cigarettes or other forms of tobacco in the past 30 days. Those who reply that they have not used tobacco in the past 30 days are considered to have quit.
Interventions
- BEHAVIORAL Incentive
- BEHAVIORAL Telephone counseling
- DRUG Nicotine patches
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,816 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-02 |
| Phase | Phase 3 |
What the finished NCT01502306 record still lists
NCT01502306 is an interventional study that assigns participants to a tested intervention. Its 3,816 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (394% higher).
The record links to 0 conditions, and to 3 interventions - of which Incentive is the first listed.
NCT01502306 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01502306 about?
NCT01502306 is a clinical study titled "A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline". California Smokers' Helpline will conduct a randomized trial to evaluate 3 strategies of services and/or incentives on smoking cessation rates. This project has the following specific aims: 1. To increase tobacco cessation among Medi-Cal beneficiaries who currently smoke, and to improve the managem...
What is the current status of trial NCT01502306?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,816 participants. The study started on 2012-06. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01502306?
The interventions under investigation include: Incentive (BEHAVIORAL), Telephone counseling (BEHAVIORAL), Nicotine patches (DRUG).
Who is sponsoring clinical trial NCT01502306?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01502306's enrollment target sits among peer trials
3,816 66th of 2000 higher than 1,935 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia